Matthew McManus

Insider Reports History

Entity: Individual
Location: 15 Elizabeth Drive, Chelmsford, MA
Signature: /s/ Andrew Nick as Attorney-in-Fact for Matthew McManus pursuant to Power of Attorney previously filed.
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew McManus:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Azenta, Inc.	EVP & Chief Operating Officer	COMMON	29.5K	$1.67M	$56.60	Aug 19, 2022	Direct
BIO-TECHNE Corp	President - DGS	Performance Restricted Stock Units	15.8K	$1.16M	$73.55	Feb 1, 2025	Direct
BIO-TECHNE Corp	President - DGS	Restricted Stock Units	9.24K	$680K	$73.55	Feb 1, 2025	Direct
BIO-TECHNE Corp	President - DGS	Common Stock	2.98K	$219K	$73.55	Feb 1, 2025	Direct
BIO-TECHNE Corp	President - DGS	Stock Option (Right to Buy)	21.3K			Feb 1, 2025	Direct
BIO-TECHNE Corp	President - DGS	Performance Stock Option (Right to Buy)	7.95K			Feb 1, 2025	Direct

Showing 1 to 6 of 6 entries

Insider Reports Filed by Matthew McManus

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
TECH	BIO-TECHNE Corp	Feb 1, 2025	3	-$121K	4	Feb 4, 2025	President - DGS
TECH	BIO-TECHNE Corp	Aug 15, 2024	1	$0	4/A	Feb 3, 2025	President - DGS
TECH	BIO-TECHNE Corp	Feb 1, 2024	4	$0	4	Feb 5, 2024	President - DGS
TECH	BIO-TECHNE Corp	Jan 8, 2024	0	$0	3	Feb 5, 2024	President - DGS
AZTA	Azenta, Inc.	Aug 19, 2022	1	$502K	4	Aug 22, 2022	EVP & Chief Operating Officer
AZTA	Azenta, Inc.	Jan 24, 2022	0	$0	3	Feb 2, 2022	EVP & Chief Operating Officer